MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Orthofix Medical Cash and Cash Equivalents 2011-2025 | OFIX
Annual Cash and Cash Equivalents Orthofix Medical
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83.2 M | 33.1 M | 50.7 M | 87.8 M | 96.3 M | 69.7 M | 69.6 M | 81.2 M | 39.6 M | 63.7 M | 36.8 M | 28.9 M | 30.8 M | 32.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 96.3 M | 28.9 M | 57.4 M |
Quarterly Cash and Cash Equivalents Orthofix Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62.9 M | 65.6 M | 58 M | 83.2 M | 30.1 M | 26.4 M | 27 M | 33.1 M | 33.7 M | 37.6 M | 50 M | 50.7 M | 51.7 M | - | 71.9 M | 87.8 M | 82.7 M | 80 M | 94.6 M | 96.3 M | 96.3 M | 96.3 M | 96.3 M | 69.7 M | 69.7 M | 69.7 M | 69.7 M | 69.6 M | 69.6 M | 69.6 M | 69.6 M | 81.2 M | 81.2 M | 81.2 M | 81.2 M | 39.6 M | 39.6 M | 39.6 M | 39.6 M | 63.7 M | 63.7 M | 63.7 M | 63.7 M | 36.8 M | 36.8 M | 36.8 M | 36.8 M | 28.9 M | 28.9 M | 28.9 M | 28.9 M | 30.8 M | 31.1 M | 31.1 M | 31.1 M | 32.7 M | 33.2 M | 33.2 M | 33.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 96.3 M | 26.4 M | 55.6 M |
Cash and Cash Equivalents of other stocks in the Medical devices industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Apyx Medical Corporation
APYX
|
43.7 M | $ 3.86 | -3.26 % | $ 134 M |  USA |
 |
BioSig Technologies
BSGM
|
142 K | - | 37.08 % | $ 85.7 M | USA |
 |
Abiomed
ABMD
|
233 M | - | - | $ 17.2 B | USA |
 |
Cutera
CUTR
|
144 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Bio-Rad Laboratories
BIO
|
488 M | $ 307.92 | -1.93 % | $ 8.69 B | USA |
 |
Apollo Endosurgery
APEN
|
57 M | - | - | $ 475 M | USA |
 |
Acutus Medical
AFIB
|
19.2 M | - | -26.83 % | $ 2.62 M | USA |
 |
Bruker Corporation
BRKR
|
183 M | $ 45.13 | -2.67 % | $ 6.72 K | USA |
 |
Allied Healthcare Products
AHPI
|
3.32 M | - | 3.58 % | $ 2.21 M | USA |
 |
Conformis
CFMS
|
48.7 M | - | - | $ 16.4 M | USA |
 |
Abbott Laboratories
ABT
|
7.62 B | $ 125.1 | 1.48 % | $ 218 B | USA |
 |
Boston Scientific Corporation
BSX
|
414 M | $ 92.34 | 0.64 % | $ 136 B | USA |
 |
EDAP TMS S.A.
EDAP
|
24.7 M | $ 2.56 | 8.94 % | $ 95.5 M |  France |
 |
Invacare Corporation
IVC
|
58.8 M | - | - | $ 24.7 M | USA |
 |
Cardiovascular Systems
CSII
|
66.4 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
7.03 M | $ 0.92 | -4.72 % | $ 14.8 M | USA |
 |
IRadimed Corporation
IRMD
|
52.2 M | $ 96.35 | -1.06 % | $ 1.22 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
43.8 M | $ 17.7 | -3.46 % | $ 408 M | USA |
 |
Neovasc
NVCN
|
51.5 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
429 M | $ 62.79 | -1.82 % | $ 3.41 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
70.9 M | $ 2.53 | 0.86 % | $ 99 M | USA |
 |
Dynatronics Corporation
DYNT
|
326 K | - | 14.99 % | $ 929 K | USA |
 |
InMode Ltd.
INMD
|
68.9 M | $ 14.56 | 0.76 % | $ 1.15 B |  Israel |
 |
Cognyte Software Ltd.
CGNT
|
78.6 M | $ 9.88 | 0.05 % | $ 709 M | Israel |
 |
Myomo
MYO
|
5.35 M | $ 1.06 | -1.85 % | $ 7.47 M | USA |
 |
Second Sight Medical Products
EYES
|
18.4 M | - | -0.97 % | $ 54.4 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
246 M | $ 13.41 | -4.56 % | $ 1.03 B | USA |
 |
NuVasive
NUVA
|
249 M | - | - | $ 2.07 B | USA |
 |
Align Technology
ALGN
|
1.04 B | $ 165.15 | 0.78 % | $ 12.4 B | USA |
 |
Accuray Incorporated
ARAY
|
57.4 M | $ 1.07 | -3.18 % | $ 110 M | USA |
 |
Avinger
AVGR
|
5.28 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
20.1 M | $ 12.81 | -1.23 % | $ 346 M | USA |
 |
FONAR Corporation
FONR
|
46.8 M | $ 14.86 | -0.03 % | $ 97.4 M | USA |
 |
AxoGen
AXGN
|
27.6 M | $ 30.33 | 1.15 % | $ 1.34 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
239 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
1.02 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
24.5 M | $ 40.78 | 2.33 % | $ 1.26 B | USA |
|
LENSAR
LNSR
|
16.3 M | $ 11.48 | -0.17 % | $ 132 M | USA |